JohnCAffeldtMD
Ophthalmology • Loma Linda, CAAssociate Professor, Ophthalmology, Loma Linda University School of Medicine
Dr. Affeldt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11370 Anderson St
Ste 1800
Loma Linda, CA 92354Phone+1 909-558-2154Fax+1 909-558-2180
Education & Training
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 1982 - 1983
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 1977 - 1982
Keck School of Medicine of the University of Southern CaliforniaClass of 1977
Certifications & Licensure
CA State Medical License 1978 - 2026
American Board of Ophthalmology Ophthalmology
Clinical Trials
- Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK Start of enrollment: 2015 Feb 01
Publications & Presentations
PubMed
- 3 citationsTopical cenegermin associated ocular surface and contact lens drug precipitate deposit formation.Craig A White, John Affeldt
American Journal of Ophthalmology Case Reports. 2022-09-01 - 156 citationsTopical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial.Stephen C. Pflugfelder, Mina Massaro-Giordano, Victor L. Perez, Pedram Hamrah, Sophie X. Deng
Ophthalmology. 2020-01-01 - 8 citationsNo pathogenic mutations identified in the TGFBI gene in polymorphic corneal amyloid deposition.Anthony J. Aldave, Sylvia A. Rayner, Julie A. King, Andrew K. Salem, Apiradi Prechanond
Cornea. 2006-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
